Core Insights - Quantum BioPharma Ltd. has received a Product License from Health Canada for its natural health product Qlarity, allowing it to sell the product in Canada [1][2][3] - Qlarity is designed to support energy production, metabolism, electrolyte balance, physical energy, motor performance, fatigue reduction, endurance, mental alertness, and cognitive performance [2][3] Company Overview - Quantum BioPharma is focused on developing innovative biopharmaceutical solutions for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders [4] - The company is advancing its lead compound, Lucid-MS, which aims to prevent and reverse myelin degradation associated with multiple sclerosis [4] - Quantum BioPharma retains a 20.10% ownership stake in Unbuzzd Wellness Inc., which markets the dietary supplement unbuzzd™, and is entitled to a 7% royalty on sales until reaching $250 million, after which the royalty will decrease to 3% [4]